P/E Ratio Insights for Edwards Lifesciences
Portfolio Pulse from Benzinga Insights
Edwards Lifesciences Inc. (NYSE:EW) has seen a 0.01% spike in its current market session, with its price at $71.15. However, the stock has decreased by 4.81% over the past month and by 14.51% over the past year. The company's P/E ratio of 31.48 is lower than the aggregate P/E ratio of 65.16 in the Health Care Equipment & Supplies industry, which could indicate that the stock is undervalued or that it might perform worse than its industry peers.
October 12, 2023 | 6:45 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Edwards Lifesciences Inc.'s stock has seen a slight increase but has been decreasing over the past month and year. Its lower P/E ratio compared to the industry average could indicate potential undervaluation.
The company's stock has seen a slight increase in the current market session but has been decreasing over the past month and year. Its P/E ratio, which is lower than the industry average, could indicate that the stock is undervalued, which might attract investors. However, it could also suggest that the stock might perform worse than its industry peers, which could deter some investors.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100